|
ZMYM1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.4386050390699E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65189972811675E-10 |
| Normal-vs-Stage2 |
3.32549998649512E-09 |
| Normal-vs-Stage3 |
4.03660438408338E-11 |
| Normal-vs-Stage4 |
3.36219940777482E-12 |
| Stage1-vs-Stage2 |
8.462200E-01 |
| Stage1-vs-Stage3 |
3.055000E-01 |
| Stage1-vs-Stage4 |
2.064500E-02 |
| Stage2-vs-Stage3 |
6.122200E-01 |
| Stage2-vs-Stage4 |
1.343770E-01 |
| Stage3-vs-Stage4 |
2.355400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.65439908836629E-11 |
| Normal-vs-AfricanAmerican |
1.189960E-04 |
| Normal-vs-Asian |
3.27479998674107E-09 |
| Caucasian-vs-AfricanAmerican |
2.036200E-01 |
| Caucasian-vs-Asian |
8.436000E-01 |
| AfricanAmerican-vs-Asian |
3.383600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.05130015803923E-10 |
| Normal-vs-Female |
4.35840252777098E-11 |
| Male-vs-Female |
9.248800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.21400009436934E-10 |
| Normal-vs-Age(41-60Yrs) |
7.25269844181753E-11 |
| Normal-vs-Age(61-80Yrs) |
4.82429651782468E-11 |
| Normal-vs-Age(81-100Yrs) |
8.5902000002136E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.181400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.796400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.264800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.710800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.397400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.875000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.090400E-02 |
| Classical-VS-Follicular |
6.702300E-02 |
| Classical-VS-Other |
7.541200E-01 |
| Classical-VS-Normal |
1.60960000883392E-09 |
| Tall-VS-Follicular |
3.536000E-01 |
| Tall-VS-Other |
4.145000E-01 |
| Tall-VS-Normal |
3.30580007812387E-11 |
| Follicular-VS-Other |
7.855800E-01 |
| Follicular-VS-Normal |
1.08789977026902E-10 |
| Other-VS-Normal |
5.777800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.99570385059656E-11 |
| Normal-vs-N1 |
4.60420590542299E-12 |
| N0-vs-N1 |
1.876760E-01 |
|
|
